510P Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice

2016 ◽  
Vol 27 (suppl_9) ◽  
Author(s):  
C. Inagaki ◽  
T. Shimoi ◽  
H.S. Okuma ◽  
A. Kawachi ◽  
A. Shimomura ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Daily Practice ◽  
Advanced Soft Tissue Sarcoma ◽  
Eribulin Mesylate ◽  
Safety And Efficacy

scholarly journals 510P Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice

2016 ◽  
Vol 27 ◽  
pp. ix165-ix166
Author(s):  
C. Inagaki ◽  
T. Shimoi ◽  
H.S. Okuma ◽  
A. Kawachi ◽  
A. Shimomura ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Daily Practice ◽  
Advanced Soft Tissue Sarcoma ◽  
Eribulin Mesylate ◽  
Safety And Efficacy

Phase II study of eribulin mesylate in patients (pts) with advanced soft tissue sarcoma (STS).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 10567-10567 ◽  
Author(s):  
Yoichi Naito ◽  
Akira Kawai ◽  
Nobuhito Araki ◽  
Toshifumi Ozaki ◽  
Hideshi Sugiura ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Soft Tissue Sarcoma ◽  
Eribulin Mesylate

scholarly journals Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Axel Le Cesne ◽  
Sebastian Bauer ◽  
George D. Demetri ◽  
Guangyang Han ◽  
Luca Dezzani ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Advanced Soft Tissue Sarcoma ◽  
Safety And Efficacy ◽  
Subgroup Analyses
Sign in / Sign up

Export Citation Format

Share Document